A significant increase in STAT3 ubiquitination was also observed in CRC tissues after α-hederin treatment (Fig. 10G) in parallel, and western blot experiments showed that the proteasome inhibitor MG132 reversed the degradation of STAT3 by α-hederin (Fig. 10H). Here, STAT3 is linked to colorectal carcinoma.